„Novartis“

Poor clinical trial results for the drug have lowered Novartis’ stock value

This was reported a few days after the company announced poor and long-awaited Phase III clinical trial results for a heart disease drug, which were also worse than expected. Read more The district court will announce the decision in the case of Irma Gajauskaitė regarding riots and incitement on October 22 Novartis shares in Zurich…

New drugs increased Novartis sales in the second quarter

admin2 months ago2 months ago01 mins

Swiss pharmaceutical giant Novartis announced on Tuesday that the group’s sales in the second quarter of this year exceeded expectations, driven by various new products.

Bikers’ noise near Kaunas mosque: Žalimas calls it chamizmu, Sinica urges authorities to stop migration

Elite stability: Zverev in the third consecutive “Grand Slam” final

40-year-old Lady Gaga gave birth to her first child: first photos are spreading

On the Lithuanian track – rivals driven by fierce fans

Why does the stomach hurt most often: a doctor advises how to recognize dangerous symptoms

Lithuanian building a business in India: “Here you can dance with a prince or drink tea next to a cow”

After Israel’s strike on a Hezbollah target – Visit of the Lebanese president to the south of the country

Shelton, who recorded a record assist, advanced to the US Open final

Officers’ words turned into disinformation: has it really been decided to mobilize women in Ukraine?

“Harley Davidson” already allocated funds for autism research: after the wastrel’s confession, vaccine skeptics rejoice

Poor clinical trial results for the drug have lowered Novartis’ stock value

New drugs increased Novartis sales in the second quarter